When your lab receives a shipment of vitrified donor oocytes from Asian Egg Bank, the quality of the warming and fertilization process directly determines what the intended parents will have available for transfer. The eggs arrive in excellent condition - cryopreserved using established vitrification protocols - but the steps your embryology team takes from the moment of warming through fertilization, culture, and blastocyst assessment are where clinical expertise determines outcomes.

This guide covers the key stages of the warming and fertilization workflow for frozen Asian donor oocytes, the quality checkpoints to apply at each stage, and the areas where coordination between your lab and AEB supports the smoothest possible process for your patients.

Confirming Shipment Integrity Before Warming

Vitrified oocytes are shipped in certified cryogenic containers designed to maintain liquid nitrogen levels throughout transport. Before warming, your embryology team should:

• Confirm the dewar arrived with the liquid nitrogen level intact and no evidence of temperature excursion
• Verify that the documentation from AEB matches the number of straws received and the donor identification
• Confirm the warming date and time align with the intended parent's endometrial preparation protocol

Asian Egg Bank coordinates directly with your lab to confirm shipment timing and to provide the donor's vitrification records. If there is any discrepancy in documentation or any concern about shipment integrity, contact AEB before beginning the warming process. Fertilizing oocytes from a compromised shipment is not recoverable.

The Warming Process: Step-by-Step Considerations

Oocyte warming should follow your lab's validated warming protocol, typically using a commercial warming kit (such as Kitazato or Irvine Scientific warming media) matched to the vitrification media used during freezing. AEB can confirm which media system was used for your specific lot.

Key considerations during warming:

• Temperature control is critical. Warming media should be pre-equilibrated to 37°C. Fluctuations in temperature during the warming steps are among the most common causes of reduced survival rates.
• Follow timing precisely. The sequence of warming solution exposures - from high-concentration sucrose solutions through dilution steps to standard culture media - has defined time windows. Rushing or extending any step risks osmotic damage to the oocyte.
• Assess survival before moving forward. After allowing warmed oocytes to stabilize in culture (typically 2 to 4 hours at 37°C in 5-6% CO2), assess each oocyte for signs of survival. A surviving MII oocyte will show a clear zona pellucida, intact cytoplasm without signs of lysis or fragmentation, and extrusion of the first polar body. Degenerated oocytes should be removed before fertilization.
• Document survival rate per cohort. Your survival data per shipment is valuable both for the intended parent's clinical management and for the aggregate outcomes tracking that AEB maintains. Typical survival rates for vitrified oocytes from established programs range from 75 to 90 percent per warmed oocyte, though this varies by donor and lot. Report your survival count to AEB as part of the post-warming communication.

Fertilization: ICSI as the Standard Approach

Intracytoplasmic sperm injection (ICSI) is the standard fertilization method for cryopreserved donor oocytes and should be used rather than conventional insemination (IVF). This is because the zona pellucida of a vitrified oocyte may be hardened compared to a fresh oocyte, and conventional insemination carries a meaningfully lower fertilization rate in this context.

ICSI should be performed on confirmed MII oocytes approximately 3 to 6 hours after warming stabilization, once you've confirmed the oocyte has recovered from the warming process. Injecting too early - before the oocyte has stabilized - increases the risk of premature activation or failure.

Fertilization check is performed approximately 16 to 18 hours after ICSI. Normal fertilization is confirmed by the presence of two distinct pronuclei (2PN) and two polar bodies. Oocytes showing one pronucleus (1PN) or three or more (polyploidy) should be separated and not used for transfer. Your fertilization rate per warmed and surviving oocyte is the next key metric to document and communicate to AEB.

Embryo Culture: From Fertilization to Blastocyst

Fertilized oocytes should be cultured in a low-oxygen environment (5-6% CO2, 5-6% O2, balance N2) with a validated sequential or single-step culture medium. Continuous monitoring using a time-lapse incubator (if your lab has one) provides the most granular data on early developmental kinetics without disturbing the embryos through repeated opening of the incubator.

Key culture checkpoints:

• Day 2-3: assess for cleavage and early cellular division. Expected: 4-cell to 8-cell embryos depending on timing.
• Day 5: assess for blastocyst formation. Expanded blastocysts ready for transfer or vitrification (for freeze-all and deferred transfer cycles) should be graded using a standardized system such as the Gardner-Schoolcraft grading scale.
• PGT-A: if the intended parent and their physician have elected preimplantation genetic testing for aneuploidies, trophectoderm biopsy should be performed on Day 5 or Day 6 blastocysts prior to vitrification. Coordinate biopsy logistics (sending to the genetics lab, timeline) before the cycle begins.

Reporting and Communication With Asian Egg Bank

AEB tracks clinical outcomes across its partner clinics to monitor program quality and support continuous improvement. Following your cycle, AEB will typically request a post-cycle outcomes report covering:

• Number of oocytes received
• Number successfully warmed and surviving
• Number fertilized (2PN)
• Blastocyst formation rate
• Number of embryos transferred or vitrified
• Pregnancy outcomes where available

This reporting is part of the authorized partner clinic agreement. It helps AEB maintain the quality assurance function that allows it to accurately communicate expected outcomes to future intended parents. Your participation in outcomes reporting is what keeps the entire program's transparency intact.

Frequently Asked Questions

What warming media should we use for AEB vitrified oocytes?

AEB can confirm the specific vitrification system and media used for each lot so your lab can use the matched warming kit. Contact AEB's clinical team before your scheduled warming date to confirm.

What survival rate should we expect from AEB vitrified oocytes?

Based on published data on vitrified donor oocytes from established programs, survival rates of 75 to 90 percent per warmed oocyte are typical. Individual donor and lot variability exists. AEB can provide historical survival data for programs where available.

Can we use these oocytes with TESE/micro-TESE sperm?

Yes. ICSI is compatible with surgically retrieved sperm. Coordinate with your andrology team on sperm preparation timing to align with the warming and stabilization window.

What if our survival rate is significantly lower than expected?

Contact AEB immediately. Document the warming steps and any deviations from protocol. AEB's clinical team will review the case and determine whether the outcome is within expected variance or whether there is a protocol or shipment issue to investigate.

Are AEB's frozen donor egg cohorts available for clinics outside the United States?

Yes. AEB supports international partner clinics. Shipping logistics, import/export requirements, and regulatory considerations vary by country.

How do we communicate our clinic's interest in becoming an AEB-authorized partner?

Start by contacting the team to discuss authorization requirements, documentation, and onboarding.

How many oocytes are typically included in a frozen egg cohort from Asian Egg Bank?

Cohort sizes vary depending on the donor and the package selected. Intended parents and clinics should confirm cohort composition before the cycle begins, particularly if preimplantation genetic testing (PGT-A) is planned, which typically requires a larger starting number of oocytes to yield a sufficient number of euploid embryos for transfer.

What is the recommended timing between oocyte warming and ICSI injection?

ICSI should be performed on confirmed MII oocytes approximately 3 to 6 hours after the warming stabilization period - once the oocyte has demonstrated recovery from the cryopreservation process. Injecting too early, before the spindle apparatus has re-polymerized following warming, increases the risk of failed fertilization or chromosomal abnormalities from premature activation.

What documentation does AEB provide with each shipment for regulatory and lab compliance?

Each AEB shipment is accompanied by documentation that includes the donor identification and matching information, vitrification records (media system, cryoprotectant used, dates), the number and condition of straws, and the required FDA-mandated infectious disease screening results. Your lab should verify that the documentation received matches the shipment contents before beginning the warming process.

How should our lab handle and store any remaining vitrified embryos after the transfer cycle?

Vitrified blastocysts remaining after the fresh transfer cycle should be stored in your clinic's cryo-storage according to your standard protocols for vitrified embryos, under the intended parent's consent and storage agreement. AEB does not hold or manage embryos post-cycle; this responsibility falls entirely to the treating clinic and the intended parents.

What specific PGT-A considerations apply when working with donor egg cohorts from AEB?

When PGT-A is planned, biopsy timing and logistics should be coordinated before the cycle begins - including which genetics laboratory will receive the biopsy samples, the expected turnaround time for results, and how the freeze-all protocol will be structured. AEB can provide historical data for specific donor lots where available to support planning.

Are there any specific considerations for labs using time-lapse incubation systems with AEB oocytes?

Time-lapse incubation is compatible with and beneficial for culture of embryos derived from frozen donor oocytes, as it reduces incubator openings and provides granular data on developmental kinetics. Standard time-lapse protocols apply, and no protocol modifications specific to donor oocyte origin are required.

Partner With Asian Egg Bank's Clinical Team

Asian Egg Bank's frozen donor egg program is designed to support strong clinical outcomes through rigorous donor screening, quality vitrification, and transparent outcomes tracking. To connect with AEB's clinical team about lab protocols, shipment logistics, or authorized partner status, reach the team directly.

Contact Our Clinical Team ->